Armenia vs Belarus: The number of people with susceptibility test result for rifampicin
Armenia
100
in 2021
Belarus
100
in 2021
Armenia rank
2nd
Belarus rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Armenia
- Belarus
How they compare
Armenia currently reports 100 against 100 in Belarus, a difference of 0.
Across all 5 years both countries report, Belarus has been ahead every year.
Armenia ranks 2nd and Belarus ranks 2nd of 146 countries.
Belarus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Belarus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.02 | 100 | 1.98 | Belarus |
| 2020s | 99.75 | 100 | 0.2512 | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Armenia or Belarus?
- Armenia, at 100 against 100 in Belarus as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Armenia and Belarus?
- 0, with Armenia ahead.
- How many years of comparable data are there for Armenia and Belarus?
- 5 years are reported by both, from 2017 to 2021.
- How do Armenia and Belarus rank globally for the number of people with susceptibility test result for rifampicin?
- Armenia ranks 2nd and Belarus ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.